Dr Malcolm Barratt-Johnson discussed the role of a medical affairs team and how they can make a strategic impact to improve healthcare outcomes. Malcolm suggested that medical affairs teams have a growing and increasingly important role in leading a company’s overall strategy, focusing though on therapeutic choice opposed to product alone. To do this, medical affairs has to develop a greater set of leadership skills and a greater skill base.
Malcolm drew on his experience of working in the medical sector of pharmaceutical & biotechnology companies and raised some salient points around the role of medical affairs teams. They should be able to:
Tim Warren focused on generating evidence via the Delphi methodology. This recognised, scientific and structured approach can help medical affairs teams to communicate the application of complex science to stakeholders across markets. As healthcare is advancing quickly and there are new innovations creating some ambiguity in practice, expert opinion is increasingly necessary.
Delphi consensus is a recognised approach already applied regularly to healthcare situations and Triducive’s expertise amplifies the output to create further weight behind expert recommendations. The final output of a Triducive-led Delphi consensus is a peer reviewed manuscript (offering Level 4 evidence). Thus, this research can be cited and referenced in further initiatives.
The strategic impact of a Delphi campaign can help:
The meeting wrapped up with a lively Q&A. Nick Williams posed questions from the audience to Dr Malcolm Barratt-Johnson and Tim Warren. Questions included:
Watch the webinar recording to hear Dr Malcolm Barratt-Johnson and Tim Warren explore these topics in detail and hear their answers to the questions by clicking below.
To suggest topics for our next meeting, email info@triducive.com / hello@pharmamedic.com
|
|